Research Paper Volume 16, Issue 7 pp 6537—6549
A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma
Figure 7. Predicting the survival of patients with different clinicopathological features, including age (age >65 and ≤65), gender, T stage (T1-2, T3-4), AJCC stage (stage I–II and stage III–IV), and pathological grade (G1-2 and G3-4) using the RS model.